Although some supply constraints have eased since early shortages were declared for several GLP-1 receptor agonists, access and GLP-1 shortage concerns persist as utilization continues to outpace production in certain segments of the market
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications primarily prescribed for type 2 diabetes management and, in some formulations, for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
There are times we may need to approve a drug before we cover it
Weinstock RS, Guerci B, Umpierrez G, Nauck MA, Skrivanek Z, Milicevic Z
GLP-1 receptor agonists GLP-1 receptor monoagonists According to their pharmacodynamics and pharmacokinetic properties, the GLP-1RAs are categorized as either short-acting or long-acting agents
This level of effectiveness highlights the substantial health benefits Ozempic can offer to those struggling with obesity or overweight issues
&srotate=0)
